logo
I Nearly Died From 'Broken Heart Syndrome' — And Here's Why You Could Be At Risk, Too

I Nearly Died From 'Broken Heart Syndrome' — And Here's Why You Could Be At Risk, Too

Yahoo5 days ago
'I hope you're taking care of yourself.'
That's the line that's been coming at me for years now –– across my texts, LinkedIn DMs and voicemails, across dinner tables and Slack messages, and haven't-seen-you-in-forever emails.
I know people mean well. I can feel their complicated mix of sympathy, pity and thank-God-it's-not-me relief.
But the words roll off tongues with an ease and frequency usually reserved for basic, mindless tasks –– not the truly daunting business of righting yourself after being pummeled by one (or more) of adult life's most stressful experiences.
According to The Holmes-Rahe Stress Inventory, I've been through a whole host of those experiences –– some of them a few times over.
My father and maternal grandmother both died of cancer the same year, I've moved more than a dozen times since graduating from college, and I've lost three jobs.
In the past year alone, I've gotten laid off; had my 3-year-old son diagnosed with a rare, difficult-to-control epilepsy; and tested positive for COVID on my birthday.
My friends have dubbed me 'a warrior,' 'a real-life superhero,' and 'the queen of coping.' And while I don't know if those are fully-earned monikers in a country where almost 38 million people are living below the poverty line, I've admittedly asked myself: Is this a normal amount of stuff to deal with?
But at the end of the day, I know I'm not special. At the very least, we're all being subjected to the truly head-banging soundtrack of everything that's going wrong in this world, including deep-rooted racism, misogyny, gun violence, natural disasters, political turmoil, the aftershocks of a global pandemic, and more.
And these chronic stressors –– in addition to isolated events –– are heavy contributors to any given person's cumulative stress level.
But we keep on keeping on, right?
After being repeatedly Whack-a-Mole-d by a few of life's most stressful events, I continued making plans where I could. I started my own business, and I scheduled an elective plastic surgery I'd been considering for a long time. I was excited about the expected results after staring at a postpartum body I barely recognized for three-plus years.
So, on Jan. 17, 2023, at 5:30 a.m., I arrived at the hospital for my surgery. The night before, I half-jokingly said to my mom and my husband, Pearse: 'If anything happens to me, I love you!'
'You'll be fine!' They both replied in rapid succession.
'I know, I know,' I said. 'I'm just saying it.'
They put me in bay number 13 for the surgery prep. I wondered aloud to Pearse over the phone if that was bad luck. We quickly chuckled about it and then it was time for me to go to the induction room.
The anesthesia team gave me some medication to calm my nerves, wheeled me into the operating room, and put me to sleep.
About 10 minutes later, everything went sideways.
My medical team couldn't get a pulse on me –– femoral, radial, carotid –– nothing. They started CPR.
After a few minutes, they were able to resuscitate me, and I was emergently transferred to the cardiac catheterization lab.
When I regained consciousness later that day, I tried to take stock of my surroundings and my body.
I was still out of it from the anesthesia, but I knew this wasn't the way I had expected to wake up –– with a breathing tube down my throat and a still-undetermined amount of lines coming out of my neck, arms and hands.
I eventually learned I was in the cardiac intensive care unit, where I stayed for the rest of the week recovering from being brought back to life, undergoing invasive cardiac testing, and hosting a revolving door of medical professionals.
'Are you under any significant stress?' One of the cardiologists asked me during rounds the next morning.
I stared at him blankly.
I thought about all the days when even four anti-epileptic drugs couldn't stop our son from having close to 1,000 seizures. I thought about all the nights I'd spent picking up and putting down our resurrected baby monitor, in a constant panic that every breath, every shift, every groan from his room was a seizure. I thought about his medical ketogenic diet that requires us to painstakingly weigh every morsel of food to the tenth of a gram. I thought about holding him on his side time after time as he convulsed, staring at the stopwatch on my phone, silently begging some unknown higher being to make it stop.
I thought about losing my job six months ago in the never-ending river of tech layoffs meandering through the workforce. I had vowed to myself I wouldn't lose my professional edge through parenting, the pandemic, and getting cut from yet another full-time gig. Was that happening now that I'm self-employed and only working part-time? And do I even care anymore?
I thought about my dad –– a former pediatric anesthesiologist –– and how I wished he was there to tell me everything's going to be OK. I thought about how grief has a cruel way of forever siphoning off just a little bit of the joy that comes with every celebration-worthy event, every achievement. And I thought about how ironic it was that I'd coded on the operating table after getting anesthesia –– my dad's exact work.
Ultimately, my heart function eventually returned to normal and my medical team ruled out every cardiac condition except one: stress cardiomyopathy, also known as 'broken heart syndrome.' It's a complex condition in which the heart muscle is quickly, but temporarily, weakened, often as a result of intense emotional or physical stress.
According to my cardiologist, Dr. Anna C. O'Kelly, a fellow in cardiovascular medicine at Massachusetts General Hospital, my case, like many stress cardiomyopathy cases, isn't clear cut –– and was likely multifactorial.
'It is hard to know which came first,' said Dr. O'Kelly. 'Did you develop stress cardiomyopathy from all the many life stressors you have... which placed you 'at risk' for the cardiac arrest? Or did your body interact poorly with the anesthesia leading to your cardiac arrest, which then caused a stress cardiomyopathy?'
The role stress played in my situation is a mystery I'm still very much grappling with. And a frustrating mystery at that, because while I probably had above-average stress in my life, I wasn't just letting it go unchecked.
I've been seeing a therapist regularly since my dad died, I've test driven many stress management techniques over the years, and I'm hyper-aware of what I'm doing (or not doing) on a daily basis to fortify my mental health and well-being.
I now take an hour-long walk every day, I just finished a 12-week cardiac rehabilitation program, I joined a gym, I'm on a beta-blocker, and I've finally let myself spend a few nights away from home to sleep without staring at the baby monitor all night.
But fitting all that in on top of day-to-day life –– figuring out how to 'take care of yourself' today –– sure feels like a bonafide burden. Like that to-do list item you can never cross off. An extra responsibility that comes at you day after day with the cliché laundry list of yoga and just-10-minutes-of-meditation and daily exercise and weekly therapy and time with family and time with friends and time to yourself and time for the hobbies that help you feel like a person.
And if I –– an upper-middle class, straight, white homeowner, with a master's degree, community support, a stable of resources, and an incredible amount of privilege –– can't take care of myself in America today enough to avoid stress-induced heart failure, then how can anyone?
So, where do I go from here? Where do any of us go from here?
After all, when it comes to stress, I'm certainly not alone. According to the American Psychological Association, 27% of Americans report they are so stressed they can't function.
'That's huge,' Dr. Lynn Bufka, associate chief for practice transformation at the American Psychological Association, and a licensed psychologist in the state of Maryland, told me.
Dr. Bufka also says this type of collective, debilitating stress produces a ripple effect that seeps into just about every crevice of society.
'It's not about one person being so stressed they can't function,' she said. 'It means workplaces aren't functioning as well, students aren't learning as well.'
This type of widespread underperformance as a result of our stress only adds to our stress level, creating a vicious cycle that's very hard to break.
Plus, chronic stress –– the kind that comes from things like having your basic human rights stripped away based solely on your gender identity or sexual orientation, or caring for someone with a disability –– can impact almost every system in the body. And those resulting physical health issues (hello, broken heart syndrome) are, you guessed it, stressful.
'There is definitely a link –– which we are increasingly appreciating –– between our psychological and cardiovascular health,' said Dr. O'Kelly. 'The exact mechanism is not entirely clear, though it is likely bidirectional. For example, depression is a risk [factor] for heart disease, but you can imagine ways in which heart disease is also a risk factor for depression if you aren't able to be as active, or have shortness of breath, or frequent hospital admissions.'
Nevertheless, many of us who have the means and wherewithal, try and try again to tunnel our way through the stress wall, doing our yoga and just-10-minutes-of-meditation and daily exercise and weekly therapy and time with family and time with friends and time to ourselves and time for the hobbies that help us feel like people.
But this isn't something an açaí bowl or putting down your phone during dinner can fix. We need a lifeline.
Because in the face of no federal bereavement policy, 12 weeks of unpaid family leave, average annual child care costs coming in north of $10,000, average bachelor's degree loan debt clocking in at $28,400, a health care system that will bankrupt most people at the first sign of a significant health complication, and much more, another thing is becoming abundantly clear: Even those of us with a roof over our head and food on our table are out here falling through a safety net that was already tattered and torn at best.
Dr. Bufka acknowledges that constructing an adequate safety net –– in addition to pursuing the activities and boundaries that keep our individual stress levels in check –– is crucial in helping Americans manage their stress levels.
To be sure, that's a daunting challenge all around.
Just to lay a strong nationwide foundation, we're talking universal access to annual mental health check-ups, improved distribution of stress management resources in communities across the country, every workplace and school being equipped to take on mental health challenges, and fixing complex systemic issues –– like racism, sexism and food instability –– that contribute to chronic stress.
Of course, there are many dedicated professionals already working to make progress in these areas. But when 76% of people nationwide have stress-induced health problems, doesn't it seem like our leaders' urgent duty to help us move the needle? Shouldn't their main responsibility be to hold fast to the ideal of having a country full of people who are in a position to achieve contentment?
Can we really say we're the home of the American dream –– the land of equal opportunity for success –– if we don't address the stress elephant in the room? The simple fact is that a bunch of us are out here not functioning or literally coding on operating tables, because no matter how hard we try to chip away at our individual stressors, our country isn't meeting us halfway.
I'll happily relinquish the 'queen of coping' crown and the 'real-life superhero' cape in exchange for more systems and policies that take a little pressure off everyone.
After all, I'm just one member of an army of stressed out soldiers who I can only imagine are waving their white flags, ready to openly admit that a few weekly down dogs and sun salutations will never fully combat the stress that comes from living paycheck to paycheck, worrying your child is going to catch the next bullet, or grappling with medical trauma.
We're all warriors. We're all resilient. We can move through hard things. We can withstand the blows life deals us. We just need a little help stopping the bleeding along the way.
This story was originally published in September 2023 and is being rerun now as part of HuffPost Personal's 'Best Of' series.
Melisse Lombard is a writer, editor, content professional and former journalist, now running her own editorial content production company. She lives outside Boston with her husband, Pearse, their son, and their pup. Melisse is also a co-founder of and singer in award-winning professional a cappella group, Sound Off.
Do you have a compelling personal story you'd like to see published on HuffPost? Find out what we're looking for here and send us a pitch.
Related...
I'm A Doctor Who Almost Died Because My Own Doctors Refused To Do This 1 Basic Thing
My Doctor Offered Me A 'Modern Medical Miracle.' Then A Side Effect Changed My Life Forever.
If I'd Listened To My Doctor, I Would Be Dead Right Now
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

2 dead and 58 sick from growing Legionnaires' disease cluster in New York City
2 dead and 58 sick from growing Legionnaires' disease cluster in New York City

Yahoo

time27 minutes ago

  • Yahoo

2 dead and 58 sick from growing Legionnaires' disease cluster in New York City

Two people have died and at least 58 people have been diagnosed with Legionnaires' disease in a cluster that broke out in the Harlem area of New York City last week, officials said on Monday. The New York City Health Department had reported on Thursday that one person had died and 22 people were sick in the cluster. MORE: 1 dead and at least 22 sick from Legionnaires' disease cluster in New York City 'People living or working in the area with flu-like symptoms, such as cough, fever, chills, muscle aches, or difficulty breathing should contact a health care provider immediately,' the department said in a statement on Monday. 'It is especially important for people at higher risk -- including those ages 50 and older, cigarette smokers, and people with chronic lung disease or compromised immune systems -- to get care if they have symptoms.' Legionnaires' disease is a type of pneumonia that is caused by the bacteria Legionella, which grows in warm water, health officials said, and people can get Legionnaires' disease by breathing in water vapor that contains Legionella bacteria. MORE: Teen suffers 'significant thermal burns' near Yellowstone geyser MORE: Man sentenced to time served for trying to open plane door, stab flight attendant in neck "Anyone in these zip codes with flu-like symptoms should contact a health care provider as soon as possible," said Acting Health Commissioner Dr. Michelle Morse. "Legionnaires' disease can be effectively treated if diagnosed early, but New Yorkers at higher risk, like adults aged 50 and older and those who smoke or have chronic lung conditions, should be especially mindful of their symptoms and seek care as soon as symptoms begin." Legionnaires' disease can be caused by plumbing systems where conditions are favorable for Legionella growth, such as cooling towers, whirlpool spas, hot tubs, humidifiers, hot water tanks and evaporative condensers of large air-conditioning systems, health officials said. People can get Legionnaires' disease by breathing in water vapor that contains Legionella bacteria, though officials reminded people that the disease cannot be transmitted from person to person and can be treated with antibiotics. MORE: Cocaine worth more than $1 million seized at Texas border, CPB says The respiratory disease takes its name from an outbreak at the Pennsylvania American Legion convention held at the Bellevue-Stratford Hotel in Philadelphia in July 1976 and the bacterium believed to be responsible is found in soil and grows in water, such as air-conditioning ducts, storage tanks and rivers. No details about the two people who died have been released by officials as of Tuesday. Solve the daily Crossword

Purespring Therapeutics receives UK CTA approval for Phase I/II clinical trial of PS-002 in patients with primary IgA nephropathy (IgAN)
Purespring Therapeutics receives UK CTA approval for Phase I/II clinical trial of PS-002 in patients with primary IgA nephropathy (IgAN)

Yahoo

time27 minutes ago

  • Yahoo

Purespring Therapeutics receives UK CTA approval for Phase I/II clinical trial of PS-002 in patients with primary IgA nephropathy (IgAN)

First patient in Phase I/II clinical trial expected to be enrolled in Q4 2025 UK Clinical Trial Application (CTA) approval shortly follows U.S. IND clearance and granting of European Medicine Agency (EMA) orphan drug designation, enabling readiness for initiation across sites in both the U.S. and Europe PS-002, Purespring's lead precision nephrology programme, targets the complement pathway known to be a driver of IgA nephropathy and is supported by a wealth of preclinical data London – 5 August 2025 - Purespring Therapeutics, a precision nephrology company focused on transforming the treatment of kidney diseases, today announces that its UK Clinical Trial Application (CTA) for a planned Phase I/II study of PS-002, Purespring's lead programme, in patients with IgA nephropathy (IgAN) has been approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA), the NHS Health Research Authority (HRA) and Research Ethics Committee (REC). 'The CTA approval for our Phase I/II clinical trial of PS-002 represents another key milestone as we complete our transition to a clinical-stage precision nephrology company,' said Haseeb Ahmad, Purespring's Chief Executive Officer. 'Building on the recent FDA IND clearance and EMA orphan drug designation, this further validates the potential of our podocyte-targeting approach to go beyond symptom management and directly target kidney disease at its source. Looking ahead, we are committed to working closely with regulators and sites across the U.S. and Europe with the view to expand the therapeutic options available for people living with IgAN.' PS-002 was developed to target the underlying cause of many kidney diseases by modulating complement activation in the kidney via precision targeting of podocytes. The programme is initially focused on the treatment of IgA nephropathy (IgAN), a rare and chronic autoimmune kidney disease that primarily affects young adults. In IgAN, aberrant immunoglobin A (IgA) protein becomes trapped in the kidney's filters, known as the glomeruli, causing complement activation, inflammation, damage and scarring. A significant proportion of affected patients will go on to develop kidney failure despite currently available therapies. The Phase I/II clinical trial, which is expected to enroll its first patient in Q4 2025, will evaluate local administration of PS-002 to treat IgAN. In the Phase 1 part of the Phase I/II study, the main read-outs will be safety parameters, which, together with efficacy biomarkers, will be leveraged to select a dose for the Phase 2 part of the study. This second phase will be used to further define the safety profile and provide early markers of efficacy. Enabled by this latest regulatory approval and the recent U.S. IND clearance, as announced in July 2025, the Phase I/II study will recruit patients across the U.S. and Europe. For further information, contact: Purespring: Peter Mulcahycontact@ (0)20 3855 6324LinkedIn ICR Healthcare Amber Fennell, Sarah Elton-Farrpurespring@ Notes to Editors About Purespring Purespring is developing therapies to halt or prevent kidney disease, one of humankind's most poorly treated disease areas. Founded on the work of Professor Moin Saleem, Professor of Paediatric Renal Medicine at the University of Bristol, Purespring is the first company to successfully treat kidney disease by targeting the podocyte, a specialised cell that is implicated in the majority of renal disease. Purespring's platform approach enables streamlined gene therapy development for both acquired and genetic renal diseases, offering the potential to halt, reverse and even cure both rare and common kidney diseases. The Company currently has a pipeline of programmes in development including the lead asset for treatment of IgA Nephropathy (IgAN) and other complement mediated kidney disease. The Company also has programmes for disease caused by mutations in the gene NPHS2, as well as other monogenic glomerular kidney diseases. Based in London, the Purespring team combines world-leading expertise in podocyte biology and kidney disease with a wealth of experience in gene therapies, anchored in a culture of diversity, creativity and delivery. Purespring is backed by leading biotech investors, including Syncona Limited, Sofinnova Partners, Gilde Healthcare, Forbion, and the British Business Bank and has raised £115m ($149m) to date. For more information please visit: and follow us on in to access your portfolio

Cognitive Impact From Dementia Risk Factors Greater in Women
Cognitive Impact From Dementia Risk Factors Greater in Women

Medscape

time28 minutes ago

  • Medscape

Cognitive Impact From Dementia Risk Factors Greater in Women

TORONTO — A number of modifiable risk factors are more common in women than in men and have a greater impact on cognition, an early look at new research showed. Six modifiable dementia risk factors were more prevalent in women, whereas only three were more common in men. Investigators also found that the impact on cognition from some of these factors was greater in women than in men, especially hearing loss and diabetes. However, the impact of these and other risk factors varied by age. Megan Fitzhugh, PhD The results suggest personalized health and lifestyle interventions should consider both sex and age, study author Megan Fitzhugh, PhD, assistant professor, Department of Neurosciences, University of California San Diego, told Medscape Medical News. 'Clinicians should familiarize themselves with the 14 identified modifiable risk factors, and if their patients have these risk factors, consider their sex and age, and try to target the behavior changes accordingly to minimize the impact on cognition and dementia risk,' Fitzhugh said. The findings were presented on July 28 at the Alzheimer's Association International Conference (AAIC) 2025. At Greater Risk It's well-known that women are at greater risk for dementia. The lifetime risk for Alzheimer's disease (AD) is 1 in 5 for women compared with 1 in 10 for men. Sex-specific factors such as pregnancy and menopause may contribute to this imbalance. But while many researchers tackle this issue from a biological perspective, Fitzhugh focuses on the effects of modifiable risk factors. She used the 2008 wave of the Health and Retirement study, an ongoing population-based study of a representative sample of American retirees and their spouses who complete questionnaire every 2 years (in 'waves'). After excluding anyone younger than 40 years and those without self-reported risk factor information, the study sample included 17,182 individuals. Fitzhugh concentrated on items included in the Lancet Report on Dementia Prevention. As reported by Medscape Medical News , 45% of dementia risk factors are potentially modifiable. Risk factors identified in the Lancet report include less education in early life (contributing 5% to risk); hearing loss (7%), elevated low density lipoprotein (LDL) cholesterol (7%), depression (3%), traumatic brain injury (3%), physical inactivity (2%), diabetes (2%), smoking (2%), hypertension (2%), obesity (1%), and excessive alcohol (1%) in midlife; and social isolation (5%), air pollution (3%), and vision loss (2%) in late life. Looking at prevalence, investigators found that six of the 14 risk factors were more common in women, including physical inactivity, depression, smoking, poor sleep, less education and poor vision (for example, glaucoma or cataracts). Only three risk factors were more common in men, including hearing loss, diabetes, and alcohol use. There was no difference in prevalence between men and women in high BMI, hypertension, and social isolation. Plotting Cognition The Health and Retirement Study also gathers data on global cognition (immediate recall, delayed recall, numeracy, etc.) using a 27-item scale. Fitzhugh separated mean cognitive scores for men and women and for three age groups (middle age: 40-59 years; middle to older age: 60-79 years; and oldest age: 80 years and over), then plotted risk factors in each group. The graphs she created illustrate the differences in cognitive performance between having and not having a risk factor for each sex. For example, the diabetes plot shows this risk factor has a much bigger impact on cognition in women. 'The line for men is relatively flat, so their cognition is really the same if they have diabetes or not, but for women, if they have diabetes, cognition is much lower compared to women who don't have diabetes', explained Fitzhugh. In addition to diabetes, other risk factors that have a greater cognitive impact on women included poor sleep, BMI, hypertension, poor vision, less education, and hearing loss. Along with high LDL, hearing loss is the largest modifiable risk factor, accounting for 7% of dementia risk, according to the Lancet Commission report. But even though more men have hearing loss across all ages, it appears to be more impactful on women in terms of cognition, said Fitzhugh. 'Maybe we should be targeting women with hearing loss in middle to older age, making sure they get hearing aids,' she said. Elsewhere in her research, Fitzhugh found women with hearing loss have a greater risk for dementia than men with hearing loss. 'There's something about hearing loss in women that is particularly detrimental.' The cognitive impact of risk factors also varies by age, investigators found. Among women, the impact of hearing loss was greatest in middle to older age. Poor sleep only had a significant impact in middle age, which coincides with the menopause transition. And in the oldest age, less education was the only risk factor to have a significant impact on cognition. In men, only smoking had a greater cognitive impact, but interestingly, only in the older age group. 'The way I think about age in this study is it's telling us when, potentially, we should be targeting these risk factors,' said Fitzhugh. She recognizes this is 'just a snapshot' in time and said she'd like to 'map out' how risk factors impact cognition over time. Commenting on the research, Liisa Galea, PhD, Treliving Family Chair in Women's Mental Health, Centre for Addiction and Mental Health, and professor of psychiatry, University of Toronto, Toronto, Ontario, Canada, said that more modifiable factors are associated with cognition in females than males is 'most surprising.' 'Clearly these factors are important for everyone, but we need more targeted messaging to women across the lifespan about the importance of these variables for their brain health,' Galea said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store